OBI Pharma, Inc. (4174.TWO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for OBI Pharma, Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -1.73x |
| P/B Ratio | 1.88x |
| P/S Ratio | 60.62x |
| Profitability | |
| Gross Margin | -132.4% |
| Operating Margin | -3702.6% |
| Net Margin | -3504.6% |
| EBITDA Margin | -3314.8% |
| Liquidity | |
| Current Ratio | 4.51x |
| Quick Ratio | 4.45x |
| Leverage | |
| Debt/Equity | 0.27x |
YoY = year-over-year change. Source: FMP..